Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression
Primary Purpose
Lumbar Disc Prolapse With Radiculopathy
Status
Unknown status
Phase
Early Phase 1
Locations
Denmark
Study Type
Interventional
Intervention
ARO Spinal System
Sponsored by
About this trial
This is an interventional treatment trial for Lumbar Disc Prolapse With Radiculopathy
Eligibility Criteria
Inclusion Criteria:
Radicular pain and evidence of nerve-root irritation lasting 6 weeks or more as evidenced by both:
- Radicular pain - below the knee,
- Nerve root irritation
i. positive nerve root tension sign - straight leg raise positive between 30 and 70 degrees, or ii. positive femoral tension sign, or iii. neurologic deficit - asymmetrical depressed reflex or decreased sensation in a dermatomal distribution or weakness in a myotomal distribution.
- Primary one-level posterolateral herniation in the lower lumbar spine (L4-L5 or L5-S1 only) as shown by magnetic resonance (MR) imaging (protrusion, extrusion or sequestered fragment) consistent with the clinical symptoms (both level and side).
- The investigator confirms that the patient is a surgical candidate for discectomy,
- The patient has been scheduled for their surgical procedure no more than two months from time of consent,
- 18 years to 55 years of age at time of consent,
- Willing to complete the study requirements and permit agency and sponsor authorized personnel to access medical records,
- Able to understand oral and written Danish.
Exclusion Criteria:
- Previous lumbar surgery
- Cauda equine syndrome
- Scoliosis greater than 15 degrees
- Osteoporosis
- Segmental instability (> 10 degrees angular motion or >4mm translation)
- Vertebral fractures
- Spinal Infections
- Spinal tumors
- Inflammatory spondyloarthropathy
- Pregnancy or the intent to become pregnant in the following year
- Comorbid conditions contraindicating surgery
- Multiple herniations
- Known allergy to titanium, aluminum or vanadium
- Female patients of childbearing age, who are not willing to use adequate contraception specified as: intrauterine devices, hormonal contraceptives (contraceptive pills, implants, transdermal patches, hormonal vaginal devices or injections with prolonged release). It is accepted in certain cases to include subjects having a sterilized permanent partner or subjects using double barrier contraceptive methods which is a condom combined with a diaphragm.
Sites / Locations
- Aarhus University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ARO Spinal System
Arm Description
ARO Spinal System
Outcomes
Primary Outcome Measures
Safety profile compared to historical controls and improvement in leg and back pain
Secondary Outcome Measures
Oswestry Disability Index (ODI) improvement is superior to historical control
VAS back pain improvement is superior to historical control
VAS leg pain improvement is superior to historical control,
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01970514
Brief Title
Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression
Official Title
Temporary Axial Rotation Stabilization for Lumbar Disc Prolapse Surgery With the ARO® Spinal System: A Non-randomized Prospective Analysis of Clinical Efficacy, Safety and Cost Effectiveness
Study Type
Interventional
2. Study Status
Record Verification Date
January 2015
Overall Recruitment Status
Unknown status
Study Start Date
April 2012 (undefined)
Primary Completion Date
July 2015 (Anticipated)
Study Completion Date
July 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ARO Medical
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To evaluate the clinical safety and effectiveness of the ARO Spinal System and to assess preliminary cost/benefit analysis in patients undergoing decompression surgery for symptomatic lumbar disc herniations.
The general hypothesis is that the ARO significantly improves outcomes in patients undergoing decompression surgery for symptomatic lumbar disc herniations.
Detailed Description
Not provided
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Disc Prolapse With Radiculopathy
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ARO Spinal System
Arm Type
Experimental
Arm Description
ARO Spinal System
Intervention Type
Device
Intervention Name(s)
ARO Spinal System
Intervention Description
The device provides an internal axial rotation orthosis (ARO) for patients being surgically treated for herniated nucleus pulposus (HNP).
Primary Outcome Measure Information:
Title
Safety profile compared to historical controls and improvement in leg and back pain
Time Frame
One year
Secondary Outcome Measure Information:
Title
Oswestry Disability Index (ODI) improvement is superior to historical control
Time Frame
1 year
Title
VAS back pain improvement is superior to historical control
Time Frame
1 year
Title
VAS leg pain improvement is superior to historical control,
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
The percentage of patients very or somewhat satisfied with their symptoms is greater than historical control
Time Frame
1 year
Title
There is an increase in the percentage of patients with evidence of annular healing in comparison to historical control
Time Frame
1 year
Title
There is a decrease in the percentage of patients with evidence of facet degenerative changes in comparison to historical control
Time Frame
1 year
Title
There is a reduction in the percentage of patients with degenerative changes in the disc in comparison to historical control
Time Frame
1 year
Title
There is a reduction in the axial rotation motion on the operative level compared to pre-operative motion
Time Frame
1 year
Title
Surgery with the device has no neurological impact
Time Frame
1 year
Title
The rate of reherniation is less than in historical control
Time Frame
1 year
Title
The percent of patients disabled at one year is less than in historical controls
Time Frame
1 year
Title
The device has a neutral cost/benefit profile in comparison to historical controls to permit further clinical study
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Radicular pain and evidence of nerve-root irritation lasting 6 weeks or more as evidenced by both:
Radicular pain - below the knee,
Nerve root irritation
i. positive nerve root tension sign - straight leg raise positive between 30 and 70 degrees, or ii. positive femoral tension sign, or iii. neurologic deficit - asymmetrical depressed reflex or decreased sensation in a dermatomal distribution or weakness in a myotomal distribution.
Primary one-level posterolateral herniation in the lower lumbar spine (L4-L5 or L5-S1 only) as shown by magnetic resonance (MR) imaging (protrusion, extrusion or sequestered fragment) consistent with the clinical symptoms (both level and side).
The investigator confirms that the patient is a surgical candidate for discectomy,
The patient has been scheduled for their surgical procedure no more than two months from time of consent,
18 years to 55 years of age at time of consent,
Willing to complete the study requirements and permit agency and sponsor authorized personnel to access medical records,
Able to understand oral and written Danish.
Exclusion Criteria:
Previous lumbar surgery
Cauda equine syndrome
Scoliosis greater than 15 degrees
Osteoporosis
Segmental instability (> 10 degrees angular motion or >4mm translation)
Vertebral fractures
Spinal Infections
Spinal tumors
Inflammatory spondyloarthropathy
Pregnancy or the intent to become pregnant in the following year
Comorbid conditions contraindicating surgery
Multiple herniations
Known allergy to titanium, aluminum or vanadium
Female patients of childbearing age, who are not willing to use adequate contraception specified as: intrauterine devices, hormonal contraceptives (contraceptive pills, implants, transdermal patches, hormonal vaginal devices or injections with prolonged release). It is accepted in certain cases to include subjects having a sterilized permanent partner or subjects using double barrier contraceptive methods which is a condom combined with a diaphragm.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cody Bunger, MD, DrMedSc
Organizational Affiliation
Aarhus University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
DK-8000
Country
Denmark
12. IPD Sharing Statement
Learn more about this trial
Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression
We'll reach out to this number within 24 hrs